.alpha.,.alpha. dialkylbenzyl derivatives
AssigneesImperial Chemical Industries PLC, ICI Pharma
InventorsPhilip N. Edwards, David Waterson
Life of this patent
Estimating the term…
Loading patent…
AssigneesImperial Chemical Industries PLC, ICI Pharma
InventorsPhilip N. Edwards, David Waterson
Estimating the term…
The invention concerns .alpha.,.alpha.-dialkylbenzyl derivatives of the formula I ##STR1## wherein Ar.sup.1 is phenyl or naphthyl, or a 10-membered bicyclic heterocyclic moiety containing one or two nitrogen heteroatoms and optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur; A.sup.1 is a direct link to X.sup.1 or is (1-3C)alkylene; X.sup.1 is oxy, thio, sulphinyl or sulphonyl; the phenylene group may optionally bear one or two substituents R.sup.3 ; each of R.sup.1 and R.sup.2, which may be the same or different, is (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, fluoro-(1-4C)alkyl, phenyl or phenyl-(1-4C)alkyl, provided that both of R.sup.1 and R.sup.2 are not methyl or fluoromethyl; and Q is cyano, amino, nitro, formyl, (1-4C)alkoxy, thiazolyl or (2-4C)alkanoyl; or a pharmaceutically-acceptable salt thereof; processes for their manufacture; pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors.
An .alpha.,.alpha.-dialkylbenzyl derivative of the formula I
A pharmaceutical composition which comprises an .alpha.,.alpha.-dialkylbenzyl derivative of the formula I, or a pharmaceutically-acceptable salt thereof, as claimed in any one of claims 1 to 6 in association with a pharmaceutically-acceptable diluent or carrier.
Dependencies are inferred from the claim text.